Endo caves to FDA pressure, will pull Opana ER from the market

6th July 2017 Uncategorised 0

Under pressure from the FDA, Endo has decided to pull from the market its opioid painkiller Opana ER, a drug that generated nearly $160 million in sales last year.

More: Endo caves to FDA pressure, will pull Opana ER from the market
Source: fierce